cancer semaglutide decelerates the growth and progression of breast by enhancing the acquired antitumor immunity GLP-1 and cancer: Beneficial effect

Some biological markers, such as cholesterol and C-reactive protein (a measure of inflammation), remained slightly improved

A disadvantage of oral semaglutide is the frequent occurrence of gastrointestinal discomfort

Harlan Krunholz, MD wrote previously for Forbes about how a Cochrane review of studies on the efficacy and safety of Tamiflu found that "the manufacturer of the drug sponsored all the trials and the reviewers found evidence of publication and reporting biases." He added that "With so much at stake I was surprised that there had been no prospective, placebo-controlled trials conducted that were funded by an independent source." Looks like more independent scientific studies may be necessary before making more definitive conclusions about the safety of Tamiflu

Summary of Evidence Quantity of Research Available A total of 474 citations were identified in the literature search

Side effects Common side effects associated with both Tirzepatide and Semaglutide include gastrointestinal symptoms such as nausea, vomiting, and diarrhea